Pembrolizumab (anti-PD-1), dilutions start from 1 μg/ml) can bind to Immobilized recombinant Human PD-1 his tag (UA010004 form UA.BIO) at 0.5 μg/ml (50 μl/well) as coating antigen.
EC50=13.74 ng/ml
Product Details
Product Details
Product Specification
Host | Human |
Antigen | PD-1 |
Antibody Type | Recombinant mAb |
Isotype | IgG4,k |
Application | Blocking of PD-1/PD-L1 signaling Functional assays |
Reactivity | Hu |
Purification | Protein A |
Concentration | 5 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4, containing no preservative. Endotoxin level is ≤ 1 EU/mg |
Stability & Storage |
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied
|
Background
Pembrolizumab is a humanized monoclonal IgG4 kappa antibody directed against human cell surface PD-1 (programmed death receptor-1) on lymphocytes. The PD-1 receptor provides an important “immune checkpoint,” which helps prevent the immune system from attacking itself.
Picture
Picture
Validation Data

